Table 4 Mega A rounds of 2019
Company | Amount ($ millions) | Date | Region | Business |
|---|---|---|---|---|
FerGene | 570 | 25 November | Saint-Prex, Switzerland | Cancer gene therapy |
Nuvation Bio | 275 | 28 October | New York | Oncology |
Anthos Therapeutics | 250 | 27 February | Cambridge, Massachusetts | Targeted cardiovascular therapy |
Century Therapeutics | 250 | 1 July | Philadelphia, Pennsylvania | Stem cells and oncology |
Arvelle Therapeutics | 207.5 | 1 January | Zug, Switzerland | Central nervous system |
Maze Therapeutics | 191 | 27 February | South San Francisco, California | Functional genomics |
ElevateBio | 150 | 13 May | Cambridge, Massachusetts | Cell and gene therapy |
Passage Bio | 115.5 | 14 February | Philadelphia, Pennsylvania | Neurology, cell and gene therapy |
Thrive Earlier Detection | 110 | 30 May | Cambridge, Massachusetts | Diagnostic |
Kronos Bio | 105 | 18 July | San Mateo, California | Cancer |
Talaris Therapeutics | 100 | 18 April | Boston, Massachusetts | Cell and gene therapy, transplantation |
